Answer
The greatest concern is medicines processed by CYP450 enzymes that have a narrow safety margin, such as warfarin or ciclosporin. Temporary cytokine release can increase their exposure, so monitoring may be required.
Sources for this answer
- KIMMTRAK (tebentafusp) 200 micrograms/ mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.